US2021022849A1PendingUtilityA1

Breast treatment device

Assignee: LIFECELL CORPPriority: Aug 21, 2015Filed: Oct 13, 2020Published: Jan 28, 2021
Est. expiryAug 21, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61F 2/12A61L 27/362A61F 2230/0013A61L 27/3695A61L 27/3633
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides devices and methods for treating the breast. The devices can include an acellular tissue matrix having a predefined shape. The shape can include a first edge with an S-shaped configuration and a second arcuate-shaped edge. The shape alternatively can include a first concave edge and a second convex edge.

Claims

exact text as granted — not AI-modified
1 - 27 . (canceled) 
     
     
         28 . A breast treatment device, comprising:
 a sheet of acellular tissue matrix, wherein the sheet of acellular tissue matrix comprises a flexible sheet with a top surface, a bottom surface, and a peripheral border, and wherein the peripheral border comprises a first edge having a concave shape, and a convex-shaped second edge.   
     
     
         29 . The device of  claim 28 , wherein the first edge and second edge meet at a first end of the device and at a second end of the device. 
     
     
         30 . The device of  claim 29 , wherein the first end of the device comprises a first pointed tip. 
     
     
         31 . The device of  claim 30 , wherein the second end of the device comprises a second pointed tip. 
     
     
         32 . The device of  claim 29 , wherein the second end of the device comprises a rounded edge. 
     
     
         33 . The device of  claim 28 , wherein the tissue matrix comprises a tissue matrix derived from a human tissue. 
     
     
         34 . The device of  claim 28 , wherein the tissue matrix comprises a tissue matrix derived from porcine tissue. 
     
     
         35 . The device of  claim 28 , wherein the tissue matrix comprises a dermal tissue matrix. 
     
     
         36 . The device of  claim 35 , wherein the dermal tissue matrix further comprises an epithelial basement membrane on the top surface of the tissue matrix. 
     
     
         37 . A method of treating a breast, comprising:
 identifying an anatomic site within a breast;   selecting a breast treatment device comprising a sheet of acellular tissue matrix, wherein the sheet of acellular tissue matrix comprises a flexible sheet with a top surface, a bottom surface, and a peripheral border, and wherein the peripheral border comprises a first edge having a concave shape, and a convex-shaped second edge; and   implanting the treatment device in or proximate the breast; and   securing at least a portion of the treatment device along the second convex-shaped edge to tissue in or near the breast.   
     
     
         38 . The method of  claim 37 , further comprising implanting a breast implant or tissue expander within the breast. 
     
     
         39 . The method of  claim 38 , wherein the breast implant or tissue expander comprises a silicone or saline filled implant or tissue expander. 
     
     
         40 . The method of  claim 37 , wherein the treatment device is implant with the convex-shaped second edge facing inferiorly. 
     
     
         41 . The method of  claim 37 , wherein the tissue matrix comprises a tissue matrix derived from a human tissue. 
     
     
         42 . The method of  claim 37 , wherein the tissue matrix comprises a tissue matrix derived from porcine tissue. 
     
     
         43 . The method of  claim 37 , wherein the tissue matrix comprises a dermal tissue matrix. 
     
     
         44 . The method of  claim 43 , wherein the dermal tissue matrix further comprises an epithelial basement membrane on the top surface of the tissue matrix. 
     
     
         45 . The method of  claim 44 , wherein the treatment device is implanted with the top surface facing towards a chest wall of a patient in which the treatment device is implanted. 
     
     
         46 . A breast treatment system, comprising:
 a breast implant or tissue expander; and   a sheet of acellular tissue matrix, wherein the sheet of acellular tissue matrix comprises a flexible sheet with a top surface, a bottom surface, and a peripheral border, and wherein the peripheral border comprises a first edge having a concave shape, and a convex-shaped second edge.   
     
     
         47 . The breast treatment system of  claim 46 , wherein the first edge and second edge meet at a first end of the device and at a second end of the device. 
     
     
         48 . The breast treatment system of  claim 47 , wherein the first end of the device comprises a first pointed tip. 
     
     
         49 . The breast treatment system  claim 48 , wherein the second end of the device comprises a second pointed tip. 
     
     
         50 . The breast treatment system of  claim 47 , wherein the second end of the device comprises a rounded edge. 
     
     
         51 . The breast treatment system of  claim 46 , wherein the tissue matrix comprises a tissue matrix derived from a human tissue. 
     
     
         52 . The breast treatment system of  claim 46 , wherein the tissue matrix comprises a tissue matrix derived from porcine tissue. 
     
     
         53 . The breast treatment system of  claim 46 , wherein the tissue matrix comprises a dermal tissue matrix. 
     
     
         54 . The breast treatment system of  claim 53 , wherein the dermal tissue matrix further comprises an epithelial basement membrane on the top surface of the tissue matrix. 
     
     
         55 . (canceled)

Join the waitlist — get patent alerts

Track US2021022849A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.